Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Angeliq in Postmenopausal Chinese Women with Vasomotor Symptoms
NCT00356447Phase 3Completed
- Sponsor
- Bayer
- Start
- May 2006
- Primary completion
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of estradiol + drospirenone in vasomotor symptoms, sponsored by Bayer. Started May 2006; status: completed.
02
Drugs
estradiol + drospirenone
03
Conditions
vasomotor symptoms
Beyond the preview
Go deeper on NCT00356447.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00356447.